# | Title | Journal | Year | Citations |
---|
1 | Advances in diagnosis and treatment of metastatic cervical cancer | Journal of Gynecologic Oncology | 2016 | 338 |
2 | FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication | Journal of Gynecologic Oncology | 2015 | 238 |
3 | Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer | Journal of Gynecologic Oncology | 2012 | 192 |
4 | LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p | Journal of Gynecologic Oncology | 2018 | 162 |
5 | Therapeutic options for management of endometrial hyperplasia | Journal of Gynecologic Oncology | 2016 | 140 |
6 | Clinical characteristics of struma ovarii | Journal of Gynecologic Oncology | 2008 | 139 |
7 | Epidemiology of gynecologic cancers in China | Journal of Gynecologic Oncology | 2018 | 137 |
8 | Clinical statistics of gynecologic cancers in Japan | Journal of Gynecologic Oncology | 2017 | 120 |
9 | Maximal cytoreductive effort in epithelial ovarian cancer surgery | Journal of Gynecologic Oncology | 2010 | 118 |
10 | Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update | Journal of Gynecologic Oncology | 2017 | 113 |
11 | Role of aggressive surgical cytoreduction in advanced ovarian cancer | Journal of Gynecologic Oncology | 2015 | 110 |
12 | Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study | Journal of Gynecologic Oncology | 2011 | 109 |
13 | Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010 | Journal of Gynecologic Oncology | 2013 | 106 |
14 | Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women | Journal of Gynecologic Oncology | 2016 | 105 |
15 | Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism | Journal of Gynecologic Oncology | 2018 | 105 |
16 | Current status of gynecologic cancer in Japan | Journal of Gynecologic Oncology | 2009 | 102 |
17 | Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan | Journal of Gynecologic Oncology | 2013 | 99 |
18 | Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research | Journal of Gynecologic Oncology | 2016 | 99 |
19 | Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS) | Journal of Gynecologic Oncology | 2020 | 97 |
20 | Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives | Journal of Gynecologic Oncology | 2016 | 94 |
21 | Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer | Journal of Gynecologic Oncology | 2017 | 94 |
22 | Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer | Journal of Gynecologic Oncology | 2017 | 93 |
23 | Immunotherapy in endometrial cancer: new scenarios on the horizon | Journal of Gynecologic Oncology | 2019 | 91 |
24 | Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer | Journal of Gynecologic Oncology | 2019 | 89 |
25 | Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases | Journal of Gynecologic Oncology | 2009 | 88 |
26 | Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma | Journal of Gynecologic Oncology | 2017 | 84 |
27 | Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015 | Journal of Gynecologic Oncology | 2019 | 81 |
28 | Clinical significance of human papillomavirus genotyping | Journal of Gynecologic Oncology | 2016 | 79 |
29 | DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers | Journal of Gynecologic Oncology | 2015 | 76 |
30 | Current status of gynecological cancer in China | Journal of Gynecologic Oncology | 2009 | 74 |
31 | Surgical therapy of vulvar cancer: how to choose the correct reconstruction? | Journal of Gynecologic Oncology | 2016 | 72 |
32 | Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study | Journal of Gynecologic Oncology | 2015 | 71 |
33 | Current status of cervical cancer and HPV infection in Korea | Journal of Gynecologic Oncology | 2009 | 70 |
34 | Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass | Journal of Gynecologic Oncology | 2011 | 69 |
35 | Trends in gynecologic cancer mortality in East Asian regions | Journal of Gynecologic Oncology | 2014 | 69 |
36 | Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia | Journal of Gynecologic Oncology | 2010 | 67 |
37 | Gynecological cancer in Indonesia | Journal of Gynecologic Oncology | 2009 | 66 |
38 | Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically | Journal of Gynecologic Oncology | 2017 | 65 |
39 | Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues | Journal of Gynecologic Oncology | 2008 | 64 |
40 | Ultrasound guided conformal brachytherapy of cervix cancer: survival, patterns of failure, and late complications | Journal of Gynecologic Oncology | 2014 | 62 |
41 | Controversies in borderline ovarian tumors | Journal of Gynecologic Oncology | 2015 | 61 |
42 | The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells | Journal of Gynecologic Oncology | 2010 | 59 |
43 | Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer | Journal of Gynecologic Oncology | 2016 | 59 |
44 | Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients | Journal of Gynecologic Oncology | 2019 | 59 |
45 | Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms | Journal of Gynecologic Oncology | 2020 | 59 |
46 | Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients | Journal of Gynecologic Oncology | 2014 | 58 |
47 | External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma | Journal of Gynecologic Oncology | 2017 | 58 |
48 | Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis | Journal of Gynecologic Oncology | 2017 | 58 |
49 | Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer | Journal of Gynecologic Oncology | 2009 | 57 |
50 | Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial | Journal of Gynecologic Oncology | 2015 | 57 |